Aglepristone
- Level
- Commodity
- Parent
- 51351600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51351602This classification denotes an anti-progestin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UT4JLE1CM. European Medicines Agency schedules Aglepristone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05285MIG. Aglepristone generally arises in the molecular formula C29H37NO2. The term AGLEPRISTONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34.) AGLEPRISTONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aglepristone under HS 29225000 and SITC 51467. As of Q4 2014, AGLEPRISTONE remains the US FDA Preferred Term for this commodity. Aglepristone bears US NLM identifiers UMLS ID C0963581 and NCI Concept Code C78092. SMILES: OC1(C2(C(C3C(=C4C(=CC(=O)CC4)CC3)C(C2)c2ccc(N(C)C)cc2)CC1)C)/C=C\C.
Same parent
Under 51351600 · 35Activities that produce or sell this
KBLI · 8Inherited from family 51350000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.